title: HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition.
abstract: Cell cycle control of histone H4 gene transcription is mediated by the multipartite promoter domain H4-Site II, which supports transcriptional activation at the G1/S phase transition and modulates basal H4 gene transcription. Proliferation-specific transcription is determined by the integrated activities of three distinct promoter factors interacting with H4-Site II: the interferon regulatory factor IRF-2 (synonymous with HiNF-M), HiNF-D (a complex between the homeodomain protein CDP-cut and the cell cycle mediators CDC2, cyclin A and pRB), as well as HiNF-P/H4TF-2. However, the contribution of HiNF-D to the enhancement and/or suppression of H4 gene transcription at specific cell cycle stages remains to be established. We used a panel of synchronized HeLa S3 cell lines containing stably integrated H4 promoter/CAT reporter gene constructs with mutations in H4-Site II. The temporal regulation of CAT mRNA accumulation under the control of the H4 promoter was analyzed by RNase protection analysis. Our main finding is that mutation of the HiNF-D/CDP-cut binding site alters the timing of histone gene activation during the cell cycle. Furthermore, our data indicate that HiNF-P/H4TF-2 may functionally compensate for HiNF-M/IRF-2 at Site II to regulate histone H4 gene transcription in HeLa S3 cervical carcinoma cells during early S phase. We postulate that HiNF-D (CDP-cut/cyclin A/CDC2/pRB containing complex) promotes HiNF-M/IRF-2 (and/or HiNF-P/H4TF-2) dependent histone H4 gene activation at the G1/S phase transition and attenuates H4 gene transcription at later cell cycle stages. The mechanistic division in the gene regulatory functions of the three H4-Site II binding proteins may ensure that histone H4 gene expression is stringently coupled with the onset of S phase in response to growth factor/cytokine-induced cell cycle progression.
authors.affiliation: Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655, USA.
authors.forename: F
authors.initials: F
authors.lastname: Aziz
authors.forename: A J
authors.initials: AJ
authors.lastname: van Wijnen
authors.forename: J L
authors.initials: JL
authors.lastname: Stein
authors.forename: G S
authors.initials: GS
authors.lastname: Stein
mesh_terms: D001483:Base Sequence; D001665:Binding Sites; D002453:Cell Cycle / Q000502:physiology*; D002795:Choline O-Acetyltransferase / Q000235:genetics; D004268:DNA-Binding Proteins / Q000502:physiology*; D016193:G1 Phase / Q000502:physiology; D006657:Histones / Q000235:genetics*; D006801:Humans; D050836:Interferon Regulatory Factor-2; D008969:Molecular Sequence Data; D009154:Mutation / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D012097:Repressor Proteins; D016196:S Phase / Q000502:physiology; D013997:Time Factors; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic / Q000502:physiology*
chemical_list: D004268:DNA-Binding Proteins; C071109:HINF-D protein, human; D006657:Histones; C494229:IRF2 protein, human; D050836:Interferon Regulatory Factor-2; D012333:RNA, Messenger; D012097:Repressor Proteins; D014157:Transcription Factors; D002795:Choline O-Acetyltransferase